Last Updated on October 29, 2021 by The Health Master
Homegrown pharma major Sun Pharmaceutical Industries Ltd said it has launched its medicine ILUMYA.
This drug is used in the treatment of adults with moderate-to-severe plaque psoriasis in Canada.
The company said ILUMYA (tildrakizumab injection) has already completed a five-year study based on a pooled analysis of two Phase 3 efficacy and safety extension trials in moderate-to-severe plaque psoriasis.
Glenmark launches unique fixed dose combination drug for Diabetes
AstraZeneca launches Clinical Trial Data division in India
MSN Labs launches Empagliflozin tablets for diabetes in India
Intas launches the World’s first SB-100mg Itraconazole
West launches 0.5mL standard syringe device in India
Biocon launches Everolimus tablets in US
FDA Haryana: Webinar organized for the Chemists of Haryana
India largest Generic Medicine supplier in the World
Experts give suggestions to take the Medical Devices Industry forward
Pharmexcil asks Pharma Exporters to register their products with Namibia directly…
NABL 164 released : Guidelines for Inter-laboratory comparison
Govt releases draft policy for R&D, Pharma and Medical Devices
Govt extends validity of licences of Distilleries to mfr Hand Sanitizer
NPPA sets up PMRUs in 19 states and Union Territories
Procedure to obtain license for manufacturing of Homoeopathic Medicines
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
